Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
5.12
+0.04 (0.79%)
At close: Apr 28, 2026, 4:00 PM EDT
5.12
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Lifecore Biomedical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | May '25 May 25, 2025 | May '24 May 26, 2024 | May '23 May 28, 2023 | May '22 May 29, 2022 | 2021 - 2017 |
| Revenue | 129.46 | 128.87 | 128.26 | 103.27 | 111.27 | Upgrade
|
| Revenue Growth (YoY) | 0.46% | 0.47% | 24.20% | -7.19% | 10.31% | Upgrade
|
| Cost of Revenue | 88.85 | 88.57 | 86.41 | 75.28 | 72.2 | Upgrade
|
| Gross Profit | 40.61 | 40.3 | 41.85 | 27.99 | 39.07 | Upgrade
|
| Selling, General & Admin | 33.35 | 44.05 | 38.76 | 38.97 | 34.66 | Upgrade
|
| Research & Development | 8.51 | 8.26 | 8.58 | 8.74 | 7.84 | Upgrade
|
| Operating Expenses | 41.87 | 52.3 | 47.34 | 47.71 | 42.5 | Upgrade
|
| Operating Income | -1.26 | -12.01 | -5.49 | -19.72 | -3.43 | Upgrade
|
| Interest Expense | -27.17 | -22.17 | -18.15 | -17.58 | -15.47 | Upgrade
|
| Interest & Investment Income | 0.47 | 0.33 | 0.06 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -2.26 | 0.41 | 36.45 | -0.81 | 6.57 | Upgrade
|
| EBT Excluding Unusual Items | -30.21 | -33.44 | 12.87 | -38.11 | -12.33 | Upgrade
|
| Merger & Restructuring Charges | - | 1.75 | -1.66 | -4.18 | -8.36 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -6.99 | - | 2.11 | - | Upgrade
|
| Other Unusual Items | - | - | -1.7 | -23.74 | - | Upgrade
|
| Pretax Income | -30.21 | -38.67 | 9.51 | -63.93 | -20.69 | Upgrade
|
| Income Tax Expense | 0.58 | 0.04 | 0.18 | 0.31 | -5.21 | Upgrade
|
| Earnings From Continuing Operations | -30.79 | -38.72 | 9.33 | -64.24 | -15.48 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 2.68 | -35.33 | -101.24 | Upgrade
|
| Net Income to Company | -30.79 | -38.72 | 12.01 | -99.56 | -116.72 | Upgrade
|
| Net Income | -30.79 | -38.72 | 12.01 | -99.56 | -116.72 | Upgrade
|
| Preferred Dividends & Other Adjustments | 3.71 | 5.64 | - | - | - | Upgrade
|
| Net Income to Common | -34.5 | -44.36 | 12.01 | -99.56 | -116.72 | Upgrade
|
| Shares Outstanding (Basic) | 37 | 35 | 30 | 30 | 29 | Upgrade
|
| Shares Outstanding (Diluted) | 37 | 35 | 37 | 30 | 29 | Upgrade
|
| Shares Change (YoY) | 7.33% | -5.02% | 22.36% | 1.67% | 0.59% | Upgrade
|
| EPS (Basic) | -0.92 | -1.27 | 0.39 | -3.32 | -3.96 | Upgrade
|
| EPS (Diluted) | -0.93 | -1.27 | 0.33 | -3.32 | -3.97 | Upgrade
|
| Free Cash Flow | 6.23 | -13.62 | -18.14 | -38.92 | -52.53 | Upgrade
|
| Free Cash Flow Per Share | 0.17 | -0.39 | -0.49 | -1.30 | -1.78 | Upgrade
|
| Gross Margin | 31.37% | 31.27% | 32.63% | 27.10% | 35.11% | Upgrade
|
| Operating Margin | -0.97% | -9.32% | -4.28% | -19.10% | -3.08% | Upgrade
|
| Profit Margin | -26.65% | -34.42% | 9.37% | -96.41% | -104.89% | Upgrade
|
| Free Cash Flow Margin | 4.81% | -10.57% | -14.14% | -37.69% | -47.21% | Upgrade
|
| EBITDA | 8.24 | -3.98 | 2.47 | -7.04 | 14.23 | Upgrade
|
| EBITDA Margin | 6.37% | -3.09% | 1.92% | -6.82% | 12.79% | Upgrade
|
| D&A For EBITDA | 9.5 | 8.03 | 7.95 | 12.68 | 17.66 | Upgrade
|
| EBIT | -1.26 | -12.01 | -5.49 | -19.72 | -3.43 | Upgrade
|
| EBIT Margin | -0.97% | -9.32% | -4.28% | -19.10% | -3.08% | Upgrade
|
| Effective Tax Rate | - | - | 1.92% | - | - | Upgrade
|
| Revenue as Reported | 129.46 | 128.87 | 128.26 | 103.27 | 111.27 | Upgrade
|
| Advertising Expenses | - | - | - | 0.01 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.